NCT01581177View on ClinicalTrials.gov

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

August 31, 2012

Conditions
Asthma
Interventions
DRUG

Albuterol DPI 25 mcg/inh

Albuterol DPI with 25 mcg Albuterol/inhalation

DRUG

Albuterol DPI 90 mcg/inh

Albuterol DPI with 90 mcg Albuterol/inhalation

DRUG

Placebo DPI

Placebo DPI with 0 mcg Albuterol/inhalation

DRUG

Albuterol MDI 90 mcg/inh

Albuterol MDI with 90 mcg Albtuerol/inhalation

Trial Locations (4)

78130

Amphastar Site 0030, New Braunfels

78229

Amphastar Site 0032, San Antonio

95117

Amphastar Site 0001, San Jose

97504

Amphastar Site 0025, Medford

Sponsors
All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY